MedCareInChina3d ago

CAR-T cell therapy pricing globally:

- US: $400-500K list ($700K-$1M actual)
- UK private: £300-500K
- AU self-pay: $500K+ AUD
- China NMPA: $160-220K USD all-inclusive

6 NMPA-approved products. Full sourced breakdown (US/UK/AU/China):
https://telegra.ph/CAR-T-Cell-Therapy-How-Chinas-160-220K-All-Inclusive-Compares-to-the-US-UK-and-Australia-06-11

#CART #Oncology #MedicalTourism

CAR-T Cell Therapy: How China's $160-220K All-Inclusive Compares to the US, UK, and Australia

CAR-T cell therapy is one of the most advanced cancer treatments developed in the last decade. For relapsed or refractory B-cell lymphoma, acute lymphoblastic leukaemia, and multiple myeloma, it has produced durable remissions. It is also one of the most expensive treatments in modern medicine, and cost varies enormously depending on where you receive it. United States: $400K-$500K list, $700K-$1M+ actual The three FDA-approved CD19 CAR-T products (Yescarta, Kymriah, and Carvykti/Tecartus depending on indication)…

Telegraph
MedCareInChina3d ago

MENA to China for medical care:

Most complex government insurance landscape of any region. UAE Thiqa/Daman/Enaya, KSA MOH treatment-abroad program, Kuwait KSAA referrals — each works differently for overseas care.

Full sourced guide:
https://medcareinchina.com/from-the-middle-east-and-north-africa-to-china-for-medical-care-government-programs-insurance-pathways-costs-and-a-decision-framework/

#MedicalTourism #MENA

From the Middle East and North Africa to China for Medical Care: Government Programs, Insurance Pathways, Costs, and a Decision Framework – MedCareInChina

MedCareInChina3d ago

Australia to China for medical care:

- AU public hip wait: 175 days median
- AU public knee: 271 days
- AU private hip: $25-32K AUD
- China public IMD: $8-12K USD

Medicare has no RHCA with China. Full sourced guide:
https://medcareinchina.com/from-australia-to-china-for-medical-care-medicare-waits-phi-blind-spots-insurance-pathways-and-a-decision-framework/

#MedicalTourism #Australia

From Australia to China for Medical Care: Medicare Waits, PHI Blind Spots, Insurance Pathways, and a Decision Framework – MedCareInChina

MedCareInChina3d ago

USA to China for medical care:

- US hip self-pay: $40-80K
- CAR-T list: $400-500K (actual $700K-$1M+)
- China public hip: $8-12K
- China CAR-T: $160-220K all-inclusive

HSA/FSA-eligible. Full sourced guide:
https://medcareinchina.com/from-the-usa-to-china-for-medical-care-insurance-gaps-self-pay-pathways-costs-and-a-decision-framework/

#MedicalTourism #USHealthcare

From the USA to China for Medical Care: Insurance Gaps, Self-Pay Pathways, Costs, and a Decision Framework – MedCareInChina

MedCareInChina3d ago

UK to China for medical care:

- NHS hip wait: 18-30 weeks
- UK private hip: £17-22K
- China public IMD: $8-12K with English support
- China private intl: $15-22K

Full sourced guide:
https://medcareinchina.com/from-the-uk-to-china-for-medical-care-nhs-waits-private-costs-insurance-pathways-and-a-decision-framework/

#MedicalTourism #NHS #ChinaHealthcare

From the UK to China for Medical Care: NHS Waits, Private Costs, Insurance Pathways, and a Decision Framework – MedCareInChina

The Japan Times3d ago
A growing number of foreign nationals are traveling to China for life-saving treatments as the cost and availability of cutting-edge procedures propels the country into a rising hub for medical tourism. https://www.japantimes.co.jp/news/2026/06/11/asia-pacific/china-medical-tourism-health/?utm_medium=Social&utm_source=mastodon #asiapacific #china #eastasia #health #medicaltourism
China lures foreign patients with cutting-edge, cheap medical care

While traditional medical tourism hotspots such as Thailand and South Korea focus on services like cosmetic surgery, China is differentiating itself with advanced procedures.

The Japan Times
MedBridgeNZJun 6

Advanced Medical Infrastructure: Shanghai Ruijin Hospital

Shanghai Ruijin Hospital is shifting global healthcare pathways through cellular therapies and 5G robotic surgery. Navigating this clinical infrastructure requires precision. MedBridgeNZ manages the administrative and logistical friction of cross-border healthcare, allowing you to focus entirely on recovery. Tap the link in our bio to structure your international medical itinerary.

#MedicalTourism #RuijinHospital #MedicalConcierge

D_Edward_LevyJun 5
medTOUR+assist: Revenue and Benefit Generation Spotlight https://tts.traveltechnologysolutions.net/medtourassist-revenue-and-benefit-generation-spotlight/ #travel #traveltech #travelapps #mobileapps #MedicalTourism #wellnesstravel
medTOUR+assist: Revenue and Benefit Generation Spotlight – TravelTechnologySolutions.net – The Newsroom

MedBridgeNZJun 5

Global Healthcare Shift: China Approves 3 Frontier Class-1 Drugs

China’s NMPA has authorized three specialized class-1 innovative therapeutics for oncology, metabolism, and vascular care
MedBridgeNZ is a medical concierge service. We do not provide medical advice or treatment.

Further Reading: https://zurl.co/B8sep

#HealthcareInnovation #MedicalConcierge #CrossBorderHealthcare #MedBridgeNZ #BiotechNews #OncologyResearch #MedicalTourism

MedBridgeNZJun 3

The Hidden Hurdle to China Medical Visas

Securing an S-series visa for complex surgery in China requires more than just clinical approval. Discover how to navigate the mandatory dual-stamp compliance audit and avoid immediate consulate rejection. Link in bio to seamlessly structure your international medical itinerary.

#MedicalTourism #GlobalHealthcare #ChinaVisa #MedicalConcierge #HealthcareLogistics #MedicalTravel

Disclaimer:MedBridgeNZ is a medical concierge service.